15.11.2022 M1 Kliniken AG  DE000A0STSQ8

EQS-News: Expansion of the Management Board of M1 Kliniken AG


 

EQS-News: M1 Kliniken AG / Key word(s): Personnel
Expansion of the Management Board of M1 Kliniken AG

15.11.2022 / 18:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


Expansion of the Management Board of M1 Kliniken AG

Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG.

Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all major business areas in Germany and abroad. In particular, he has built up the medical skin care brand M1 Select and most recently significantly improved the productivity of the clinics. Mr. Brenske is therefore excellently prepared for his new tasks as the board member responsible for national and international expansion, marketing and purchasing.

"I am very pleased about the strengthening of the board by Mr. Brenske. Together we will do everything in our power to successfully develop the M1 Med Beauty brand and thus optimally meet the needs of our customers," says Dr. Walter von Horstig, who as the existing board member will in future be responsible for the areas of finance, investor relations, inpatient clinics and administration.

 

About M1 Kliniken AG

M1 Kliniken AG is the leading provider of beauty medical health services in Germany. In the aesthetic and surgical field, the group of companies offers products and services with the highest quality standards. Under the brand "M1 Med Beauty", beauty medical treatments are currently offered at more than 50 specialist centres. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with internationalisation and is currently also active in Austria, Switzerland, the Netherlands, England, Croatia, Hungary and Australia. With its stake in HAEMATO AG, M1 Kliniken AG is also in a position to exploit sales and earnings potential of treatment products in the medical-aesthetic field.



Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M: [email protected]


15.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
E-mail: [email protected]
Internet: https://www.m1-kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1488645

 
End of News EQS News Service

1488645  15.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1488645&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 47,19 65,21 77,27 159,59 314,61 285,29 316,32
EBITDA1,2 6,18 7,17 11,33 8,89 17,82 15,41 21,01
EBITDA-Marge3 13,10 11,00 14,66 5,57 5,66 5,40
EBIT1,4 5,71 6,46 7,93 4,41 12,13 9,35 15,70
EBIT-Marge5 12,10 9,91 10,26 2,76 3,86 3,28 4,96
Jahresüberschuss1 5,78 6,61 9,73 7,43 10,88 7,07 11,67
Netto-Marge6 12,25 10,14 12,59 4,66 3,46 2,48 3,69
Cashflow1,7 2,09 2,86 -5,37 9,54 15,68 20,77 7,81
Ergebnis je Aktie8 0,38 0,39 0,56 0,37 0,45 0,22 0,54
Dividende8 0,30 0,30 0,00 0,00 0,00 0,00 0,30
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: wetreu NTRG

INVESTOR-INFORMATIONEN
©boersengefluester.de
M1 Kliniken
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0STSQ 20,700 Kaufen 406,62
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
22,26 27,32 0,81 48,14
KBV KCV KUV EV/EBITDA
3,93 52,07 1,29 18,80
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,50 2,42 17.07.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
06.06.2024 03.09.2024 19.11.2024 23.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
26,35% 71,17% 84,82% 166,75%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu M1 Kliniken AG  ISIN: DE000A0STSQ8 können Sie bei EQS abrufen


Gesundheit , A0STSQ , M12 , XETR:M12